Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1988 Dec;16(6):657-66.
doi: 10.1007/BF01062016.

The sojourn time and its prospective use in pharmacology

Affiliations

The sojourn time and its prospective use in pharmacology

G Segre. J Pharmacokinet Biopharm. 1988 Dec.

Abstract

Sojourn time in a given compartment i when the material has been injected in compartment i (Sji) corresponds to the average time spent by the particles of the material in i before their definitive exit from that compartment. Sojourn time is different from the mean residence time (tji), which is the average age of the particles leaving the system. If K denotes the transfer matrix of the compartmental system, then -K-1 provides the sojourn times in each compartment given initial arrival in each of the other compartments. It can be shown that Sji = xi(s)/xj. 0/s = 0, corresponds to the value of AUC in compartment i. Since AUCi/xj,0 = Fji.AUC/xi,0 (Fji = fraction of the dose in j reaching i), one has Sji = FjiSii.AUCi corresponds to a rectangle of height equal to xj,0 and base equal to Sii. Therefore in a compartment i a drug acts on the average for a time equal to Sii and the number of molecules in it depends on the dose and on Fji. In compartments which are not sampled the value of AUC can be calculated by a simulated curve or by -K-1. From the height of the rectangle whose area is equal to AUC one should subtract the threshold theta for a given effect; the resulting rectangle should indicate the intrinsic efficacy of the drug. These considerations could be applied in pharmacology, toxicology, and chemotherapy.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Pharm Sci. 1982 Oct;71(10):1129-33 - PubMed
    1. J Antimicrob Chemother. 1985 Jan;15 Suppl A:139-46 - PubMed
    1. Biopharm Drug Dispos. 1985 Jan-Mar;6(1):57-66 - PubMed
    1. J Pharmacokinet Biopharm. 1978 Dec;6(6):547-58 - PubMed
    1. Farmaco Sci. 1968 Oct;23(10):907-18 - PubMed